Asia/Pacific vs EU vs US Regulatory Landscape and Barriers to Entry.
Next-Generation Sequencing (NGS) for Liquid Biopsy Development and Companion Diagnostics.Epigenetic Modifications (Hypermethylation of specific genes) as Biomarkers for Diagnostics.Companion Diagnostics in Various Disease Classes.Tissue-based Biomarkers for Companion Diagnostics Development Please see below for a comprehensive list of the subject areas to be addressed. We will also highlight Emerging Technologies and Services within the Liquid Biopsy space, in addition to discussing Technology Commercialization, the Regulatory Landscape and Market Entry into Asia. The event will take place on the 13-14 October at the Biopolis, Singapore’s custom built biomedical research and development hub, home to a large number of the world’s leading Life Science organisations and A*STAR research institutes.īringing together industry professionals, entrepreneurs, researchers, academia and students, this comprehensive two day meeting will look to address the challenges of translating the latest advances in scientific research into tangible diagnostics solutions.Ī key focus for this conference track is to discuss the relative attributes of both Circulating Biomarkers and Tissue-Based Biomarkers for Companion Diagnostics.
present Singapore’s inaugural Diagnostics Summit. OverviewSelect Bio and the Diagnostics Development Hub, part of Exploit Technologies Pte. Research Director, National University Health System (NUHS)Įxecutive Director, Centre of Regulatory Excellence, Duke-NUS Medical School Singapore, Deputy Director of Medical Services (Industry & Research Matters), Ministry of Health Professor, Duke-NUS Medical School and Deputy Executive Director, Biomedical Research Council, A*STAR Global Healthcare Advisor, President, K8 Global & Senior Advisor, McKinsey&Companyįelix and Mildred Yip Endowed Chair in Dentistry Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles NUS Society Chair Professor, Department of Biomedical Engineering, Institute for Health Innovation & Technology (iHealthtech), Mechanobiology Institute, National University of Singapore Senior fellow, Consultant, Adjunct Professor, Chairman, ETPL, Duke-NUS, Inex Private Ltd Professor, New Jersey Medical School Rutgers University Founder Director/Chief Executive Officer, Biocartis
0 kommentar(er)
